Article
Monitoring of endometrial K-ras mutation in tamoxifen-treated patients with breast cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Aug 2009
Tsujioka Hiroshi, Hachisuga Toru, Fukuoka Miyoko, Ueda Taeko, Miyahara Daisuke, Horiuchi Shinji, Shirota Kyoko, Yoshizato Toshiyuki, Emoto Makoto, Miyamoto Shingo, Kawarabayashi Tatsuhiko
Abstract excerpt
INTRODUCTION: A high incidence of endometrial K-ras mutations has been reported in tamoxifen (TAM)-treated patients with breast cancer. We examined the changes in the frequency of the endometrial K-ras mutations after the cessation of TAM treatment. METHODS: DNA was extracted from fresh cytological or polypectomy samples of the endometrium in 28 patients who had undergone TAM treatment of breast cancer. Mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
